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Abstract
Background: Carbohydrates (CHOs), branched-chain amino acids (BCAAs) and caffeine are known to improve
running performance. However, no information is available on the effects of a combination of these ingredients on
performance and neuromuscular function during running.
Methods: The present study was designed as a randomized double-blind cross-over placebo-controlled trial.
Thirteen trained adult males completed two protocols, each including two conditions: placebo (PLA) and Sports
Drink (SPD: CHOs 68.6 g.L
-1, BCAAs 4 g.L
-1, caffeine 75 mg.L
-1). Protocol 1 consisted of an all-out 2 h treadmill run.
Total distance run and glycemia were measured. In protocol 2, subjects exercised for 2 h at 95% of their lowest
average speeds recorded during protocol 1 (whatever the condition). Glycemia, blood lactate concentration and
neuromuscular function were determined immediately before and after exercise. Oxygen consumption ( ˙ VO2),
heart rate (HR) and rate of perceived exertion (RPE) were recorded during the exercise. Total fluids ingested were 2
L whatever the protocols and conditions.
Results: Compared to PLA, ingestion of SPD increased running performance (p = 0.01), maintained glycemia and
attenuated central fatigue (p = 0.04), an index of peripheral fatigue (p = 0.04) and RPE (p = 0.006). Maximal
voluntary contraction, ˙ VO2, and HR did not differ between the two conditions.
Conclusions: This study showed that ingestion of a combination of CHOs, BCAAs and caffeine increased
performance by about 2% during a 2-h treadmill run. The results of neuromuscular function were contrasted: no
clear cut effects of SPD were observed.
Trial registration: ClinicalTrials.gov, http://www.clinicaltrials.gov, NCT00799630
Background
Prolonged running exercises may induce hypoglycemia,
central and/or peripheral fatigue, muscle damage,
osteoarticular disorders, inflammation and cardiovascu-
lar dysfunction [1-4]. An adapted carbohydrate (CHO)
supplement during exercise may be useful for limiting
and/or avoiding hypoglycemia and the associated distur-
bance of physical ability. Previous experiments have
shown that ingested CHOs improve performance during
exercise of longer than ~45 min [5-7]. However, the
observed improvement varies and depends, among other
things, on CHO dosage, exercise intensity and duration,
and the training status of the subjects [8,9]. For exam-
ple, Coyle showed that during a prolonged strenuous
cycling exercise (71 ± 1% ˙ VO2max) fatigue occurred
after 3.02 ± 0.19 h in a placebo trial versus 4.02 ± 0.33 h
in a CHO supplement trial (glucose polymer solution,
2.0 g.kg
-1 at 20 min and 0.4 g.kg
-1 every 20 min there-
after) [5]. During a cycling time trial, Jeukendrup et al.
[6] observed that the time needed to complete the set
amount of work was significantly shorter with CHOs
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any medium, provided the original work is properly cited.(7.6%) than with the placebo (58.7 ± 0.5 min versus 60.2
± 0.7 min, respectively), corresponding to a higher per-
centage of the subjects’ maximal work rate. It should be
noted that increased performance is not systematically
observed with CHO ingestion [10]. The mechanisms for
the beneficial effect of CHOs on performance are
thought to be via the maintenance of plasma glucose
concentrations and the high rates of exogenous CHO
oxidation in the latter stages of exercise when muscle
and liver glycogen levels are low [5,11,12].
A great deal of research has been conducted to test
different combinations of CHOs and their exogenous
oxidation. In particular, studies have demonstrated that
blends of simple carbohydrates containing fructose and
sucrose, glucose, maltose, galactose or maltodextrins
promote greater exogenous glucose oxidation than do
isocaloric glucose solutions. The difference is thought to
be due, at least in part, to the recruitment of multiple
intestinal sugar transporters (sodium glucose transpor-
ter-1 and GLUT-5) [13-16]. During exercise, the
ingested glucose is rapidly absorbed into the circulation
and oxidized by the skeletal muscle in a highly efficient
manner. In contrast, ingestion of fructose and galactose
results in less efficient oxidization probably related to
slower absorption and delays linked to hepatic metabo-
lism [17-19]. Nevertheless, when ingested at a rate
designed to saturate intestinal CHO transport systems,
fructose and galactose enhance postexercise human liver
glycogen synthesis [20].
Caffeine can also be used to extend endurance exer-
cise and improve performance. Kovacs et al. [21] identi-
fied improvements in performance during cycling time
trials when moderate amounts of caffeine (2.1 and 4.5
mg.kg
-1) were ingested in combination with a 7% CHO
solution during exercise. This effect may be partly
explained by the fact that a caffeine-glucose combina-
tion increases exogenous CHO oxidation more than
does glucose alone, possibly as a result of enhanced
intestinal absorption [22]. It is also possible that the caf-
feine causes a decrease in central fatigue [23]. In fact
caffeine can block adenosine receptors even at concen-
trations in the micromolar range [23]. Stimulation of
adenosine receptors induces an inhibitory effect on cen-
tral excitability.
Another interesting nutritional strategy to improve
performance is the ingestion of branched-chain amino
acids (BCAAs, i.e., leucine, isoleucine and valine) during
exercise. Blomstrand et al. [24] suggested that an intake
of BCAAs (7.5 - 12 g) during exercise can prevent or
decrease the net rate of protein degradation caused by
heavy exercise. Moreover, BCAAs supply during exercise
might have a sparing effect on muscle glycogen degrada-
tion [25]. It has also been postulated that BCAAs supply
during prolonged exercise might reduce central fatigue
[4]. Fatigue is generally defined as the inability to main-
tain power output [26], and can be central and/or per-
ipheral in its origin, these two factors being interrelated.
Several factors have been identified as a cause of periph-
eral fatigue (e.g., the action potential transmission along
the sarcolemma, excitation-contraction coupling (E-C),
actin-myosin interaction), whereas the factors underly-
ing central fatigue could be located at the spinal and/or
supraspinal sites. The tryptophan-5-hydroxytryptamine-
central fatigue theory has been proposed to explain how
oral administration of BCAAs can attenuate central fati-
gue [26]. During prolonged aerobic exercise, the concen-
tration of free tryptophan, and thus the uptake of
tryptophan into the brain, increases. When this occurs,
5-hydroxytryptamine (5-HT, serotonin) is produced,
which has been postulated to play a role in the subjec-
tive feelings of fatigue. Because BCAAs are transported
into the brain by the same carrier system as tryptophan,
increasing BCAAs plasma concentration may decrease
the uptake of tryptophan in the brain, and consequently
the feeling of fatigue. Nevertheless, Meeusen et al. [27]
have mentioned that brain function is not determined
by a single neurotransmitter system and the interaction
between brain serotonin and dopamine during pro-
longed exercise has also been explored as having a regu-
latory role in the development of fatigue. Hence,
Meeusen et al. [27] suggest that an increase in the cen-
tral ratio of serotonin to dopamine is associated with
feelings of tiredness and lethargy. Consequently, it can-
n o tb ee x c l u d e dt h a tt h eg i v e nr o l eo fs e r o t o n i ni nt h e
development of central fatigue is overestimated. Never-
theless, taken together these data suggest that BCAAs
supplements taken during prolonged exercise may have
beneficial effects on some of the metabolic causes of
fatigue such as glycogen depletion and central fatigue.
Consequently it is likely that a beverage containing a
mixture of CHOs, caffeine and BCAAs would improve
an athlete’s performance during endurance exercise. To
our knowledge, no information is available on the effects
of this combination on physical performance and neuro-
muscular function. The main purpose of the present
study was therefore to investigate whether ingestion of
an association of CHOs (68.6 g.L
-1), BCAAs (4 g.L
-1)
and caffeine (75 mg.L
-1) is efficient in improving physi-
cal performance and limiting alterations to neuromuscu-
lar function during a prolonged running exercise.
Methods
Subjects
Subject data are documented in Table 1. The subjects
regularly trained at least 2 - 4 times per week and had
been involved in endurance training and competition for
at least 3 months. All subjects were habitual caffeine
users (1 - 2 cups of coffee or equivalent per day). Before
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purpose and risks associated with the procedures, and
their written informed consent was obtained. All sub-
jects were healthy, as assessed by a medical examination.
The study was approved by the Southeast Ethics Com-
mittee for Human Research (France, ClinicalTrials.gov,
http://www.clinicaltrials.gov, NCT00799630).
Preliminary testing
At least 1 week before the start of the experimental
trials, an incremental exercise test to volitional exhaus-
tion was performed on a treadmill. This graded exercise
aimed i) to check the tolerance of the subjects to maxi-
mal exercise, ii) to characterize their physical fitness,
and iii) to familiarize the subjects to the use of the
treadmill and the experimental procedures. After a gen-
tle warm-up, the test started at 10 km.h
-1,a n dv e l o c i t y
was then increased by 1.5 km.h
-1 every 3 min. Oxygen
uptake ( ˙ VO2) was measured during the last minute of
each 3-min period of the maximal incremental test as
presented elsewhere [28]. Briefly, subjects breathed
through a two-way non-rebreathing valve (series 2700,
Hans Rudolph, Kansas City, Missouri, USA) connected
to a three-way stopcock for the collection of gases (100
L bag). The volume of the expired gas was measured in
a Tissot spirometer (Gymrol, Roche-la-Molière, France).
Fractions of expired gases were determined with a para-
magnetic O2 analyzer (Servomex, cell 1155B, Crowbor-
ough, England) and infrared CO2 analyzer (Normocap
Datex). The analyzers were calibrated with mixed gases,
the composition of which was determined using Scho-
lander’s method [29]. Heart rate (HR) was recorded con-
t i n u o u s l yb yar a d i ot e l e metry HR monitor (S810,
Polar
®, Tampere, Finland). Individual maximal oxygen
uptake ( ˙ VO2max) was determined as previously
described [30].
Experimental design
The study was designed as a randomized double-blind
cross-over placebo-controlled trial. The random alloca-
tion sequences were generated by an automated system
under the supervision of the committee of protection of
human subjects. The codes were kept confidential until
the end of the study when the randomisation code was
broken. All the subjects and investigators were blind to
the randomisation codes throughout the study.
The experiment comprised two exercise protocols,
each of them including two exercise tests performed in
different conditions: i.e., with ingestion of the sports
drink (SPD) or with a placebo (PLA) (see Protocols and
Figure 1 for details). The two exercise tests in protocol
1 were completed in randomized order at least one
week apart. At least one week following protocol 1, pro-
tocol 2 began. As for protocol 1, the exercise tests in
protocol 2 were performed in randomized order at least
one week apart. Subjects were instructed to maintain
their usual daily exercise activity and dietary intake (in
particular, their caffeine intake) during the study but not
to consume any solid or liquid nutrients with the excep-
tion of water for 2 h before each exercise session. All
the exercises performed by any one subject were done
at the same time of the day. The subjects were
instructed to replicate the same meal before each exer-
cise session.
Protocol 1: Performance test
Before the exercise, a 20 μL blood sample was collected
from an earlobe for the assessment of resting blood glu-
cose concentration. Then, in the 15 min preceding the
test, the subjects drank 250 mL of one of the two drinks
(PLA or SPD). Thereafter, the running test started by a
gentle warm-up followed by a 2 hour all-out exercise
trial. A beverage volume of 250 mL was provided every
15 min and drunk by the subjects within the next 15
min so that the total fluids ingested before and during
t h e2 - h o u re x e r c i s ew a s2l i t e r s .T h ev o l u m ea n d
kinetics of beverage ingestion was chosen to minimize
dehydration [16] and gastrointestinal discomfort. The
subjects ran without knowing their actual speed. An
experimenter changed the velocity of the treadmill fol-
lowing each subject’s recommendations so that they
could give their best performance during the 2-hour
exercise. At the end of the exercise a second blood sam-
ple was collected for glucose determination. Total dis-
tance (km) was recorded and average speed (km.h
-1)
was calculated. Total distance (unknown by the subject)
was considered as physical performance.
Protocol 2: Standardized exercise
A2 0μL blood sample was collected from the earlobe
for the assessment of resting glucose and lactate con-
centrations. As in protocol 1, 15 min before the test and
just before their gentle warm-up subjects drank 250 mL
Table 1 Main characteristics of the subjects
Age (yr) Body mass (kg) Height (cm) BMI (kg.m
-2) Body Fat (%) ˙ VO2max(mL.min
-1.kg
-1)
29.6 ± 9.2 71.7 ± 5.1 179.2 ± 5.7 22.4 ± 2.1 14.0 ± 3.3 59.7 ± 4.8
˙ VO2max, maximal oxygen uptake; BMI: Body mass index.
Values are means ± SD.
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hours at 95% of their individual lowest average speed
sustained in PLA or SPD during protocol 1; 250 mL of
beverage was provided every 15 min. During exercise,
˙ VCO2, ˙ VCO2, Respiratory Exchange Ratio (RER:
˙ VO2/ ˙ VO2), HR and Rate of Perceived Exertion (RPE)
were measured and/or recorded every 20 min. Central
and peripheral fatigue was evaluated before and immedi-
ately after exercise.
Material and procedures
All exercises were performed on the same treadmill (EF
1800, HEF Tecmachine, Andrezieux-Boutheon, France).
Blood lactate and glucose concentrations were deter-
mined enzymatically using a YSI 2300 (Yellow Spring
Instrument, USA). ˙ VO2 and ˙ VCO2 were measured as
described above (see paragraph Preliminary testing). RPE
was determined using the 6 - 20 point Borg scale [31].
Figure 1 Experimental design and diagram of flow of subjects through the study protocol. ˙ VO2: oxygen consumption; RER: Respiratory
Exchange Ratio; HR: heart rate; RPE: rate of perceived exertion.
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Tests were performed on the knee extensors. The sub-
jects were seated in the frame of a Cybex II (Ronkon-
koma, NY) and Velcro straps were used to limit lateral
and frontal displacements. The subjects were instructed
to grip the seat during the voluntary contractions to sta-
bilize the pelvis. The knee extensor muscles’ mechanical
response was recorded with a strain gauge (SBB 200 Kg,
Tempo Technologies, Taipei, Taiwan). All measure-
ments were taken from the subject’s right leg, with the
knee and hip flexed at 90 degrees from full extension.
The isometric contractions performed during the experi-
ment included 3-4-s maximal voluntary contractions
and electrically evoked contractions. During the 4
MVCs, the subjects were strongly encouraged. Femoral
nerve electrical stimulation was performed using a cath-
ode electrode (10-mm diameter, Ag-AgCl, Type
0601000402, Contrôle Graphique Medical, Brie-Comte-
Robert, France) pressed over the femoral nerve in the
femoral triangle, 3-5 cm below the inguinal ligament
with the anode (10.2 cm × 5.2 cm, Compex, SA, Ecu-
blens, Switzerland) placed over the gluteal fold. Electri-
cal impulses (single, square-wave, 1-ms duration) were
delivered with a constant current, high-voltage (maximal
voltage 400 V) stimulator (Digitimer, DS7A, Hertford-
shire, UK). For all stimulus modalities, stimulation
intensity corresponded to ~120% of optimal intensity, i.
e. the stimulus intensity at which the maximal amplitude
of both twitch force and the concomitant vastus latera-
lis (VL) M wave (see below) were reached.
The surface electromyographic (EMG) signal was
recorded from the right VL muscle with two pairs of
bipolar oval self-adhesive electrodes with an inter elec-
trode distance of 2.5 cm (10 mm diameter, Ag-AgCl,
Type 0601000402, Contrôle Graphique Medical, Brie-
Comte-Robert, France). The position and placement of
the electrodes followed SENIAM recommendations.
EMG data were recorded with the PowerLab system 16/
30 - ML880/P (ADInstruments, Sydney, Australia) at a
sample frequency of 2000 Hz. The EMG signals were
amplified with an octal bio amplifier - ML138 (ADIn-
struments) with bandwidth frequency ranging from 3
Hz to 1 kH (input impedance = 200 MΩ, common
mode rejection ratio = 85 dB, gain = 1000), transmitted
to a PC and analyzed with LabChart6 software
(ADInstruments).
The twitch interpolation technique was used to deter-
mine potential change in maximal voluntary activation
[32]. This consisted in superimposing stimulation at
supramaximal intensity on the isometric plateau of a
maximal voluntary contraction of the knee extensors. In
this study a high-frequency paired stimulation (doublet
at 100 Hz, Db100) was used instead of a single twitch. A
second 100 Hz doublet (control stimulation) was
delivered to the relaxed muscle 3 s after the end of the
contraction. This provided the opportunity to obtain a
potentiated mechanical response and so reduce variabil-
ity in activation level (%VA) values. The ratio of the
amplitude of the superimposed doublet over the size of
the control doublet was then calculated to obtain volun-
tary activation (%VA) as follows:
%VA =

1 −

Superimposed Db100torque/MeancontrolDb100torque

× 100
Three MVCs separated by 30 s, were performed to
determine MVC and %VA. The quadriceps muscle’s iso-
metric twitch peak torque and contraction time and VL
M-wave peak-to-peak amplitude and duration were also
analyzed. To do this, three potentiated single twitches
were evoked after a 4
th MVC and averaged. %VA
changes were considered as indices of central fatigue.
Changes in electrically evoked contraction of the relaxed
muscle (high-frequency doublet mechanical response,
peak twitch) were the outcome measures for peripheral
fatigue.
Composition of drinks
The doses of CHOs, BCAAs and caffeine were chosen
to be as close as possible to those used in previous stu-
dies [12,15,21,33,34] and the palatability of the sports
drink. For instance, due to the bitter taste of BCAAs, it
is difficult to incorporate more than 4 g.L
-1 of these
amino acids in a drink. Moreover, theses doses respect
the current legislation for dietary products. The nutri-
tional composition of SPD was as follows: maltodextrin
31.6 g.L
-1, dextrose 24.2 g.L
-1, fructose 12.8 g.L
-1,
branched-chain amino acids 4 g.L
-1, curcumin 250 mg.
L
-1,p i p e r i n e2 . 6m g . L
-1, caffeine 75 mg.L
-1, sodium 884
mg.L
-1,m a g n e s i u m1 0 0m g . L
-1,z i n c5m g . L
-1,v i t a m i n s
C1 5m g . L
-1,E5m g . L
-1, B1 0.7 mg.L
-1, B2 0.4 mg.L
-1,
B3 9 mg.L
-1. Composition of the PLA drink: malic and
citric acids, xanthan gum, acesulfame potassium, sucra-
lose, silicium dioxide, yellow FCF, tartrazine. The energy
provided by SPD and PLA was 1254 and 50 kJ.L
-1
respectively. SPD and PLA were provided by Nutratletic
(Aytre, France).
Statistical analysis
The results are presented as mean values ± SD. Because
of the lack of normality, data describing running perfor-
mance, blood glucose and lactate concentrations and
neuromuscular variables obtained in the two conditions
were compared using the non-parametric Wilcoxon test.
˙ VO2,R E R ,H R ,a n dR P Ew e r es u b j e c t e dt oat w o - w a y
repeated-measure analysis of variance describing the
effect of drink ingestion (PLA and SPD) (external fac-
tor), exercise duration (internal factor) and their interac-
tion. A p-value < 0.05 was considered as significant.
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Protocol 1: Performance test
Running distance was significantly higher, i.e.p e r f o r -
mance was better, in SPD than in PLA (22.31 ± 1.85 vs.
21.90 ± 1.69 km, n = 13, p = 0.01). Before exercise,
there was no difference in mean glucose concentrations
between PLA and SPD (5.60 ± 0.82 and 5.53 ± 0.85
mmol.L
-1, respectively, n = 13, NS). After exercise,
blood glucose was significantly lower than before exer-
cise in both groups (4.66 ± 0.48 mmol.L
-1, p < 0.001, for
PLA, and 5.26 ± 0.78 mmol.L
-1,p<0 . 0 1f o rS P D ) .T h e
changes in glycemia were significantly more pronounced
in PLA than in SPD (n = 13, p = 0.0002; Figure 2).
Expressed as a percentage, the variations in glycemia
were -16.2 ± 5.4 and -4.7 ± 2.9% for PLA and SPD,
respectively (n = 13, p = 0.0007).
Protocol 2: Standardized exercise
For personal reasons, 2 subjects dropped-out of the
study. The mean velocity during protocol 2 was 10.3 ±
0.6 km.h
-1 (n = 11). Changes in ˙ VO2,H Ra n dR P Ea r e
shown in Figure 3. For ˙ VO2 and HR, no significant
effect was observed (Figures 3A and 3B). A group and
time effect was found for RPE (n = 11, group effect: p =
0.006, time effect: p < 0.001, cross interaction: NS; Fig-
ure 3C). For RER, no differences were found between
the two conditions (data not shown). There was no dif-
ference in the glucose concentrations before exercise for
PLA and SPD (5.40 ± 0.66 and 5.44 ± 0.67 mmol.L
-1,
respectively, n = 11). Glucose concentration decreased
significantly after exercise in PLA (5.09 ± 0.60 mmol.L
-1,
n = 11, p = 0.001) but remained unchanged in SPD
(5.48 ± 0.64 mmol.L
-1, n = 11; Figure 4A). There was no
difference in lactate concentration between the two
conditions before exercise (1.65 ± 0.32 and 1.73 ± 0.42
mmol.L
-1 for PLA and SPD, respectively, n = 11). There
was a tendency towards a lower blood lactate accumula-
tion (post minus pre exercise values) in SPD (+3.48 ±
0.60 mmol.L
-1) than in PLA (+3.65 ± 0.43 mmol.L
-1)( n
Figure 2 Difference in blood glucose concentration before and
after the performance test (protocol 1). Values are means ± SD.
*** p = 0.0002.
Figure 3 Evolution of oxygen consumption (panel A), heart
rate (panel B) and Borg’s Rating of Perceived Exertion (panel
C) during the standardized exercise protocol (protocol 2).
Values are means ± SD.
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measured after exercise was significantly lower in SPD
(5.20 ± 0.39 mmol.L
-1) than in PLA (5.30 ± 0.35 mmol.
L
-1; n = 11, p = 0.01). The parameters of the
neuromuscular functions are summarized in Table 2.
The statistical analysis showed a deleterious effect of
exercise on all the parameters of neuromuscular func-
tion and a higher decline in %VA and Db100 for the
Figure 4 Difference in blood glucose (panel A) and lactate (panel B) concentrations before and after the standardized exercise
protocol (protocol 2). Values are means ± SD. *** p < 0.001.
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tions were lower in SPD than in PLA (-14% vs. -17%,
respectively), the decreases in MVC were not significant
between the two conditions.
Discussion
The main findings of the present study were that inges-
tion of the SPD containing CHOs (68.6 g.L
-1), BCAAs
(4 g.L
-1)a n dc a f f e i n e( 7 5m g . L
-1) immediately prior to
a n dd u r i n ga2ha l l - o u to rs t a n d a r d i z e de x e r c i s e1 )
increased running performance significantly, although to
a moderate extent, 2) favored the maintenance of glyce-
mia and 3) had variable effects on neuromuscular
fatigue.
Performance, i.e. total distance over a 2 h running
exercise, was significantly higher with SPD than in the
placebo condition (22.31 ± 1.85 vs.2 1 . 9 0±1 . 6 9k m ,
respectively; p = 0.01). However, the increase in physical
performance was rather small (+1.9%). Several reasons
may explain this limited improvement. Firstly, because
the subjects were not fasted (overnight), it can be
hypothesized that initial muscle and liver glycogen
stores were high, limiting the effects of SPD ingestion as
has been previously shown [15]. Secondly, the impor-
tance of nutritional strategy during exercise of less than
2 hours seems to be limited [5,6,12]. The study by Coyle
et al. [5] is of interest here. If the effect of CHO supple-
ments improved performance by 33% (182 min PLA vs.
242 min in subjects using CHO supplements) during an
exercise at 71% of ˙ VO2max, it should be noted that glu-
cose concentrations and CHO oxidation differed
between the two conditions only after 80 min and 160
min of exercise, respectively. Moreover, in a recent
meta-analysis of 72 studies, Karelis et al. [12] showed
that the mean performance effect in studies with exer-
cise durations higher than 2 h was significantly greater
than in studies with exercise durations below 2 h. Our
results agree with those of Jeukendrup et al. [6] who
found that the positive effect of CHO supplements on
performance was only 2.4% for a 1 hour exercise.
The results for neuromuscular function in the present
study are variable. Firstly, both central fatigue and an
index of peripheral fatigue (Db100) were significantly
better preserved in the SPD than in the PLA condition.
Along the same line, RPE was lower in SPD than in
PLA (Figure 3C). However, although the alterations in
MVC were lower in SPD than in PLA (-14% vs.- 1 7 % ,
respectively), the global index of neuromuscular fatigue
(MVC) did not differ significantly between SPD and
PLA. This lack of statistical difference is probably due
to high inter-individual changes in MVC. An alternative
explanation would be an alteration of excitation-con-
traction coupling or muscle fiber excitability. This may
reduce the difference between SPD and PLA when
MVC (i.e. trains of stimulations) is considered. However,
excitation-contraction coupling and muscle fiber excit-
ability do not seem to be affected by SPD as shown by
the lack of difference in the M-wave characteristics and
peak twitch changes between the two conditions.
In the present study, glycemia decreased during the
all-out exercise (protocol 1) in both conditions, but the
decrease was lower in SPD than in PLA. Furthermore,
glycemia remained stable during the standardized event
in SPD while it decreased in PLA (protocol 2). If SPD is
helpful in maintaining glycemia, it should nevertheless
be noted that the subjects were not hypoglycemic at the
end of the exercise whatever the protocol or PLA condi-
tion. It has been postulated that the improved mainte-
nance of blood glucose levels with the ingestion of
glucose may not be a potential mechanism for improved
performance during prolonged exercise [12]. However
Nybo [35] showed that when blood glucose homeostasis
was maintained by glucose supplementation, central fati-
gue seemed to be effectively counteracted and perfor-
mance (average force production) increased. Of note is
the fact that Nybo [35] detected central fatigue during a
2 min sustained maximal isometric contraction of the
Table 2 Neuromuscular variables before and after the standardized 120 min running exercise
Pre Post (Post - Pre)/Pre values * 100 (%)
PLA SPD PLA SPD PLA SPD p
MVC (Nm) 116.9 ± 18.9 117.4 ± 20.1 96.7 ± 21.0 100.6 ± 19.6 -17 ± 11 -14 ± 10 0.55
%AV 0.97 ± 0.03 0.95 ± 0.04 0.88 ± 0.09 0.89 ± 0.09 -9 ± 7 -6 ± 6 0.04
Db100 (Nm) 52.4 ± 10.4 53.6 ± 10.2 45.0 ± 9.1 47.1 ± 7.3 -14 ± 9 -6 ± 5 0.04
Pt (Nm) 32.1 ± 7.4 32.9 ± 7.2 28.3 ± 7.1 28.5 ± 5.4 -12 ± 10 -13 ± 8 0.95
CT (ms) 100.35 ± 5.60 101.17 ± 3.83 94.22 ± 5.85 95.15 ± 6.01 -6 ± 3 -6 ± 4 0.94
PPA (mV) 17.74 ± 3.07 18.33 ± 2.70 15.08 ± 2.75 15.90 ± 2.49 -15 ± 6 -13 ± 2 0.80
PPD (ms) 8.74 ± 1.55 8.79 ± 1.28 7.94 ± 1.33 8.22 ± 1.20 -9 ± 6 -6 ± 5 0.52
MVC: Maximal voluntary contraction; %AV: maximal voluntary activation; Db100: Mechanical response to a double pulse at 100 Hz; Pt: Mechanical response to a
single pulse; CT: contraction time (single twitch); PPA: M-wave peak-to-peak amplitude; PPD: M-wave peak-to peak duration.
Values are means ± SD. Statistical analysis was conducted on the (post - pre)/pre * 100 i.e., expressed in percentage (%) for PLA and SPD.
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the present study. Glucose ingestion can stimulate the
secretion of insulin and blunt the exercise-induced rise
in both free fatty acids and free tryptophan and could
consequently decrease central fatigue by attenuating the
rise in brain 5-HT (serotonin) [36,37]. Of note, RPE was
lower in SPD than in PLA (Figure 3C). Therefore, it is
possible that in the present study, maintenance of blood
glucose homeostasis indirectly acted via central fatigue
to improve performance.
During sustained exercise, BCAAs are taken up by the
muscles and their plasma concentration decreases.
Decreased plasma BCAAs levels may lead to an
increased plasma free tryptophan/BCAAs ratio, thus
favoring the transport of tryptophan into the brain and
consequently the synthesis of 5-HT. The subsequent
production of serotonin could be responsible for the
feeling of fatigue during and after sustained exercise.
Nevertheless, it has been suggested that BCAAs supple-
mentation during prolonged exercise may decrease cen-
tral fatigue via reduced tryptophan uptake and 5-HT
synthesis in the brain [4]. Indeed, because BCAAs and
free tryptophan are transported into the brain by the
same carrier system, BCCAs supplementation during
exercise would decrease the plasma free tryptophan/
BCAAs ratio. This would i) dampen the transport of
tryptophan into the brain, ii) impede the subsequent
synthesis and release of 5-HT, and consequently iii)
reduce or delay the feeling of fatigue during and after
sustained exercise
Caffeine ingestion might also affect central fatigue
[38]. Human experiments have revealed that caffeine
induces increases in central excitability, maximal volun-
tary activation, maximal voluntary force production and
spinal excitability (for review, see Kalmar and Cafarelli
[23]). The effect of caffeine on the central nervous sys-
tem could be via its action on the blockage of adenosine
receptors at concentrations in the micromolar range
[23]. Stimulation of adenosine receptors induces an inhi-
bitory effect on central excitability.
The present results show that concomitantly, CHOs,
BCAAs and caffeine supplementation reduce central
fatigue and RPE. Nevertheless, it is impossible in the
present case to distinguish the individual contribution of
each of them (CHOs, BCAAs and caffeine) in the posi-
tive effect of the sports drink on central fatigue and
RPE.
The decrease in %VA (%VA changes were considered
as indexes of central fatigue) is similar to the deficit
observed in previous studies involving running exercises
of comparable duration [39] and was only slightly,
although significantly improved by the energy drink.
The moderate influence on %VA could be explained by
t h ef a c tt h a ta tl e a s tp a r to ft h ed e c r e a s ei n% V Aa f t e r
prolonged running exercise has been attributed to the
inhibitory effect if afferent fibers [40]. In particular, this
could be due to reduced motoneurone excitability or to
presynaptic inhibition, probably resulting from thin
afferent fiber (group III-IV) signaling which may have
been sensitized by the production of pro-inflammatory
mediators produced during prolonged running exercise
(e.g. [41]). Group III-IV afferent fibers may also contri-
bute to the submaximal output from the motor cortex
[42]. It is not known whether SPD had an effect on
inflammation in the present study since no pro-inflam-
matory markers were assessed.
One limitation of this study is the fact that the volun-
teers were studied in a post absorptive state. This choice
was made in an attempt to reproduce habitual race con-
ditions since the main aim of this study was to investi-
gate if ingestion of an association of CHOs, BCAAs and
caffeine was useful in improving running performance.
Other limitation concerns the lack of control of food
intake before the trials. This may introduce variability
between the trials and potentially between the condi-
tions. Although the fact i) of performing the different
conditions in a randomized order, ii) of starting every
session at the same time of the day and iii) of instruct-
ing the subjects to replicate the same meal before each
exercise session, allows to some extent limitation of
variability between trials, it does not remove totally this
variability. A careful attention should be paid in the
future in the control of food intake before but also 2-3
days prior to testing.
Conclusions
This study has shown for the first time that ingestion of
a combination of CHOs (68.6 g.L
-1), BCAAs (4 g.L
-1)
and caffeine (75 mg.L
-1) immediately before and during
a 2 h running exercise in standardized laboratory condi-
tions significantly increased treadmill running perfor-
m a n c eb ya b o u t2 %i nt r a i n e d subjects. Moreover,
ingestion of a drink associating these components dur-
ing a standardized 2 h running exercise maintained gly-
cemia and significantly decreased RPE, central fatigue
and an index of peripheral fatigue as compared to the
placebo condition.
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